Canada markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
143.31-0.40 (-0.28%)
At close: 04:00PM EDT
146.71 +3.40 (+2.37%)
After hours: 07:42PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts21212221
Avg. Estimate-1.18-1.04-4.11-1.76
Low Estimate-1.56-1.53-5.9-4.32
High Estimate-0.27-0.09-0.961.36
Year Ago EPS-1.4-2.21-3.52-4.11
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts21202623
Avg. Estimate427.34M464.05M1.85B2.33B
Low Estimate405.65M435.5M1.78B1.88B
High Estimate452.3M565.06M2.04B2.97B
Year Ago Sales319.29M318.75M1.83B1.85B
Sales Growth (year/est)33.80%45.60%1.30%25.80%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-1.76-1.37-1.34-1.32
EPS Actual-1.4-2.211.15-1.1
Difference0.36-0.842.490.22
Surprise %20.50%-61.30%185.80%16.70%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.18-1.04-4.11-1.76
7 Days Ago-1.18-1.04-4.11-1.76
30 Days Ago-1.18-1.04-4.18-1.76
60 Days Ago-1.18-1.03-4.18-1.77
90 Days Ago-1.3-1.19-4.21-1.01
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/A11
Up Last 30 DaysN/AN/A21
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALNYIndustrySector(s)S&P 500
Current Qtr.15.70%N/AN/AN/A
Next Qtr.52.90%N/AN/AN/A
Current Year-16.80%N/AN/AN/A
Next Year57.20%N/AN/AN/A
Next 5 Years (per annum)-177.50%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A